Changes in adrenocortisol function of patients with gonadal dysgenesis after treatment with estrogen.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000096:biosynthesis; D000311:Adrenal Glands / Q000201:enzymology / Q000503:physiopathology*; D001940:Breast / Q000187:drug effects; D002986:Clinical Trials as Topic; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004958:Estradiol / Q000097:blood; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D005965:Glucuronates / Q000652:urine; D006801:Humans; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors; D007986:Luteinizing Hormone / Q000097:blood; D011085:Polycystic Ovary Syndrome / Q000503:physiopathology; D011279:Pregnanetriol / Q000652:urine*; D011863:Radioimmunoassay; D014424:Turner Syndrome / Q000503:physiopathology*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D004967:Estrogens; D005965:Glucuronates; D011279:Pregnanetriol; D004958:Estradiol; D004054:Diethylstilbestrol; D007986:Luteinizing Hormone; D006913:Hydroxysteroid Dehydrogenases